A new finding by scientists has identified key steps that trigger the disintegration of cellular regulation that leads to cancer.
Tens of thousands of women each year might be able to skip at least some of the grueling treatments for breast cancer— which can include surgery, heavy chemo and radiation— without greatly harming their odds of survival, new research suggests.
A simple blood test will soon be able to catch the vast majority of a group of chronic blood cancers, a new study reveals. The scientists also identified a new gene, CALR, which is altered in 40 percent of blood disorders.
Scientists have devised the first method to measure the push and pull of cells as embryonic tissue develops. The cells’ tiny forces are measured in 3-D tissues and living embryos.
Researchers have uncovered a genetic deficiency in males that can trigger the development of one of the most common types of liver cancer and forms of diabetes.
Harmless lung cancer? A provocative study found that nearly 1 in 5 lung tumors detected on CT scans are probably so slow-growing that they would never cause problems.
A new microchip-based device may greatly simplify the monitoring of patients’ response to treatment for ovarian cancer— the most lethal form of gynecologic cancer— and certain other malignancies.
In one of the biggest advances against leukemia and other blood cancers in many years, doctors are reporting unprecedented success by using gene therapy to transform patients' blood cells into soldiers that seek and destroy cancer.
ImmunoChemistry Technologies (ICT) has changed ownership and is now majority women-owned. The company will continue to develop new products to help researchers discover new treatments and drugs for cancer and other diseases affecting both animals and humans.
Men who continued to smoke after a cancer diagnosis had an increased risk of death compared with those who quit smoking after diagnosis, according to a new study.
In search of better cancer treatments, researchers have designed synthetic molecules that combine the advantages of two experimental RNA therapies.
The most active component of grape seed extract, B2G2, induces the cell death known as apoptosis in prostate cancer cells while leaving healthy cells unharmed, according to a new study.
Researchers have discovered how prostate cancer stem cells evolve as the disease progresses, a finding that could help point the way to more highly targeted therapies.
A byproduct of cholesterol functions like the hormone estrogen to fuel the growth and spread of the most common types of breast cancers, researchers report.
Epidemiologists have designed a better method to quantify a woman’s risk of developing breast cancer, according to researchers.
Women who are members of families with BRCA2 mutations but who test negative for the family-specific BRCA2 mutations are still at greater risk for developing breast cancer compared with women in the general population, according to a new study.
New findings show that eating a high-fat diet beginning at puberty speeds up the development of breast cancer and may actually increase the risk of cancer similar to a type often found in younger adult women.
A novel immune-boosting drug combination eradicates glioblastoma brain cancer in mice, according to a new study.
A team of scientists looking into the interplay of the immune system and cancer have found a link between a history of airborne allergies– in particular to plants, grass and trees– with risk of blood cancers in women.
Cancers that occur in later life could be down to the way our cells age, according to a new paper that says some cancers could be caused by older cells bypassing the switch that tells them to stop growing.
Chemical engineers have developed a novel way to generate nanoparticles that can recognize specific molecules, opening up a new approach to building durable sensors for many different compounds.
Using Drosophila melanogaster, researchers discovered that during multiple cell migrations a single cell can act as leader, dragging the others with it.
The protein in cells that most often drives the development of cancers has eluded scientists’ efforts to block it for three decades– until now.
Help yourself to some nuts this holiday season: Regular nut eaters were less likely to die of cancer or heart disease — in fact, were less likely to die of any cause — during a 30-year Harvard study.
The deadliest brain cancer requires grueling treatment with bleak prospects for survival. Now, researchers have discovered a key component to how these aggressive tumors grow that could lead to better solutions.